Game,

Thanks for providing link to this Cardiogenics' WDM Capital presentation; slides 16 & 17 provide important information:

Slide 16 -

1. Confirmation that 200 patient Beta Site Study to be completed in Q4 2013
2. Informs FDA Pivotal Study will require only 200 additional patients
3. Informs/confirms that FDA Pivotal Study will be conducted at Wayne State hospitals

Slide 17 -

1. FDA 200 patient Pivotal Study targeted completion date of Mid-Q1 (February?)
2. 510K submission to FDA targeted late Q3 2014 (August?)
3. Partnering discussions to complete end of Q1 2014 (Partner announcement April ?)
4. Q4 2014 Launch target date in United States

Ante